News Don’t get distracted over ARPA-H fight; let’s win the bigger prize | Maryland Daily Record Congress has approved a new agency — the Advanced Research Projects Agency for Health (ARPA-H) — that will ‘supercharge’ breakthrough…Super UserAugust 22, 2022
News Eyeing $1B in annual sales, Emergent BioSolutions to buy Narcan maker Adapt for $735M | Fierce Pharma Emergent BioSolutions is mobilizing its M&A war chest again. Hard on the heels of its $270 million deal for vaccine…Super UserAugust 22, 2022
News 8 new high priority funding opportunities We just released 8 new high priority funding opportunities where your company can make a difference in meeting the needs…Super UserAugust 19, 2022
News Maryland’s RoosterBio and Seattle’s AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies SEATTLE, Aug. 16, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today…Super UserAugust 19, 2022
News D.C. Area Life Sciences Market Down to 1.4% Vacancy – Commercial Observer The Washington, D.C./Baltimore region continued to see a tightening in its life sciences real estate market. In particular, the region…Super UserAugust 19, 2022
News Bio Tax Credit | Maryland Department of Commerce The fiscal year 2022 program is now closed. The fiscal year 2023 program will begin accepting applications as follows: Commerce…Super UserAugust 19, 2022
News Novavax Submits Application to the U.S. FDA for Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster in Adults Aged 18 and Older Aug 15, 2022 If authorized, Novavax' vaccine would be the first protein-based COVID-19 booster for adults If authorized, the Novavax…Super UserAugust 19, 2022
News Technical.ly: 2 new medtech startups will spin out of Johns Hopkins research fund grants Two new medical startups, focusing on addressing vision loss and catheter-associated urinary tract infections (UTIs), are on the horizon thanks…Super UserAugust 19, 2022
News Chancellor’s Message: VISION 2030 — From Excellence to Preeminence VISION 2030: From Excellence to Preeminence This summer, the University System of Maryland unveiled a new 10-year strategic plan—Vision 2030:…Super UserAugust 15, 2022
News Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases WALTHAM, Mass. and DUBLIN, Aug. 15, 2022 /PRNewswire/ -- Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore…Super UserAugust 15, 2022